Background: Adenomyoepithelioma of the breast is an uncommon subtype of breast neoplasm that occurs in adults over a wide age range but most commonly in middle-aged and older adults. It usually presents as a solitary palpable mass or is detected on breast radiographic images. Histologically, it is a biphasic tumor with proliferation of both the epithelial and myoepithelial components of the glands, with variable types of tissue metaplasia.

Case Presentation: A 64-year-old Saudi woman who underwent regular breast screening (mammogram) presented to our hospital following radiographic detection of a suspicious grouped microcalcification in the upper outer quadrant of her right breast on the mammogram. A wide local excision of the right breast lump was performed. Following histopathological examination of the breast lump, the final diagnosis was breast adenomyoepithelioma with mucoepidermoid/divergent differentiation, with no evidence of malignancy. About two years after the operation, a clinical follow-up conducted outside our hospital showed the development of ductal carcinoma in situ in the same breast.

Conclusion: Although the prognosis and the plan of treatment remains the same, our case highlights the complexities in making an accurate diagnosis between the various types of metaplasia within adenomyoepithelioma on one hand and the presence of mucoepidermoid differentiation in adenomyoepithelioma on the other.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358805PMC
http://dx.doi.org/10.1186/s13256-022-03507-3DOI Listing

Publication Analysis

Top Keywords

adenomyoepithelioma breast
8
breast
8
breast lump
8
adenomyoepithelioma
5
breast unusual
4
unusual confounding
4
confounding diagnostic
4
diagnostic feature
4
feature case
4
case report
4

Similar Publications

Adenomyoepithelioma (AME) is a rare variant of breast neoplasm. It is a biphasic tumour characterized by small epithelial-lined spaces with inner luminal cells and outer of abluminal (myoepithelial) cells. Either - or both - of these two cells may rarely undergo malignant transformation.

View Article and Find Full Text PDF

Salivary gland-like tumors of the breast: Histopathologic and genetic features with clinical implications.

Semin Diagn Pathol

November 2024

Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address:

Article Synopsis
  • Salivary gland-like tumors of the breast are rare and share similar features with salivary gland tumors, indicating a common origin in many cases.
  • The main types include adenoid cystic carcinoma, secretory carcinoma, and mucoepidermoid carcinoma, which are often triple negative but generally have a better prognosis than high-grade triple negative breast cancers.
  • Accurate classification of these tumors is crucial for treatment decisions, as some can be benign while others may behave aggressively, and identifying specific genetic markers can aid in diagnosis and management.
View Article and Find Full Text PDF

Adenomyoepithelioma of the Breast: A Case Report.

Cureus

September 2024

Pathology, Athens Euroclinic, Athens, GRC.

Adenomyoepithelioma (AME) is an uncommon breast tumor distinguished by the presence of both epithelial and myoepithelial cell proliferation. It often presents clinically as a well-circumscribed, non-painful mass, although it can also be asymptomatic and discovered incidentally during imaging. This case report describes a 32-year-old woman with a tumor that progressively increased in size.

View Article and Find Full Text PDF

Malignant adenomyoepithelioma of the breast in a male patient: A case report.

Asian J Surg

August 2024

Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun, Jilin Province, China. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!